Jade G.
- Country
- France
- Department
- Service des maladies infectieuses et Tropicales
Research Overview
- An Operationally Seamless Phase 2/3 Randomized, Open-label, Multicenter, Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Stable Baseline Regimen in Virologically Suppressed People With HIV-1 on Stable Complex Treatment Regimens
- Efficacy and Safety of Islatravir and Ulonivirine Once Weekly versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Once Daily in Treatment-Naïve Adults with HIV-1
- Temocillin Non-Inferiority Trial Versus Ceftriaxone for Neisseria gonorrhoeae Infections in Adults
Data & Insights
Has run more than one trial at 86 of 167 partner sites.
Specializations
HIV Treatment Innovation
The investigator specializes in evaluating novel therapeutic approaches for HIV-1 infection, particularly focusing on next-generation antiretroviral combinations and treatment strategies.
- Dual-drug regimen assessment
- Fixed-dose combination therapies
- Treatment-naïve patient interventions
Research activities encompass the evaluation of innovative drug combinations like doravirine/islatravir and bictegravir/lenacapavir for improving treatment outcomes.
HIV Prevention Studies
Focuses on advancing HIV prevention strategies through research on long-acting preventive treatments and pre-exposure prophylaxis (PrEP) methods.
- Long-acting injectable formulations
- PrEP persistence studies
- Novel preventive approaches
Investigates innovative preventive solutions including cabotegravir and lenacapavir for enhanced HIV prevention efficacy.
Specialized Therapeutic Areas
Conducts research in complex therapeutic scenarios including HIV/HBV coinfection and monkeypox prevention.
- Coinfection management strategies
- Immunological response studies
- Viral infection prevention
Explores treatment approaches for complicated clinical presentations and emerging viral threats.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.